Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Propecia Lawsuit Alleges Merck Failed to Warn of Sexual Problems in U.S. April 8, 2011 Staff Writers Add Your Comments A lawsuit has been filed against Merck, alleging that the drug manufacturer warned European men that the hair loss and prostate drug Propecia may cause sexual problems in men, but decided against providing American men the same warning. Steven Rossello, of Harlingen, Texas, and Justin Herrman, of Las Vegas, Nevada, filed a Propecia lawsuit in February against Merck in the U.S. District Court for the District of New Jersey. According to the complaint, both men were prescribed Propecia to combat male pattern hair loss, and both suffered serious sexual dysfunction, which may be permanent. The lawsuit points out that the warnings about the risk of sexual problems from Propecia differed significantly in Europe from the label warnings to users of Propecia in the U.S. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In Europe, Propecia labels stating that erectile dysfunction problems may persist after the patient discontinues use treatment with Propecia were added in 2008, after the Swedish Medical Products Agency began investigating reports of persistent erectile dysfunction problems linked to Propecia in 2006. By August 2009, the Swedish Medical Products Agency concluded that Propecia side effects can cause permanent erectile dysfunction, and Merck changed Propecia labels again to warn of the risk of permanent erectile dysfunction. However, in the United States, the label for Propecia contradicts the labels on European Propecia, stating that “these side effects went away in men who stopped taking PROPECIA because of them.” Propecia (finasteride) was approved in 1992 for the treatment of benign prostatic hyperplasia, and also is approved to treat male pattern baldness. It was originally marketed by Merck as Proscar. Last month researchers from the U.S. published a study in the Journal of Sexual Medicine that found side effects of Propecia were linked to sexual problems in men. Researchers indicated that the class of drugs known as 5-alpha-reductase inhibitors can cause loss of libido, depression erectile dysfunction, reduced semen production and growth of male breast tissue. They also agreed that in some cases these side effects appeared to be permanent. The lawsuit over Propecia charges Merck with negligence, failure to warn, strict product liability, and breach of warranty. The lawsuit is seeking compensatory damages in excess of $100,000, plus punitive damages and court costs for injuries as well as emotional distress and anxiety. Tags: Erectile Dysfunction, Merck, Product Liability, Propecia, Proscar Image Credit: | More Propecia Lawsuit Stories Propecia Side Effects Linked to Increased Risk of Depression: Study January 6, 2023 Lawsuit Seeks FDA Propecia Recall Over Risk of Depression, Erectile Dysfunction and Suicide September 14, 2021 Propecia Suicides Have Been Reported To Merck For Years: Report February 8, 2021 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025) Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITLink Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)Ozempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025) Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (Posted: 3 days ago) A Dupixent lawsuit claims that side effects of the eczema drug led to the development of a rare form of T-cell lymphoma. MORE ABOUT: DUPIXENT LAWSUITLawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (12/30/2025)Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)
Lawsuit Seeks FDA Propecia Recall Over Risk of Depression, Erectile Dysfunction and Suicide September 14, 2021
Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)
Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITLink Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)Ozempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)
Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (Posted: 3 days ago) A Dupixent lawsuit claims that side effects of the eczema drug led to the development of a rare form of T-cell lymphoma. MORE ABOUT: DUPIXENT LAWSUITLawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (12/30/2025)Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)